New patent expiration for MYLAN drug EVOCLIN
Annual Drug Patent Expirations for EVOCLIN Evoclin is a drug marketed by Mylan and is included in one NDA. There […]
Patent Expiration
New patent expiration for Mayne Pharma drug RHOFADE
Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Mayne Pharma and is included in one NDA.
New patent expiration for Mayne Pharma drug RHOFADE Read Post »
New patent expiration for Pfizer drug ZAVZPRET
Annual Drug Patent Expirations for ZAVZPRET Zavzpret is a drug marketed by Pfizer and is included in one NDA. It
New patent expiration for Eisai Inc drug HALAVEN
Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA.
New patent expiration for Eisai Inc drug HALAVEN Read Post »
Drug Patent Expirations for the Week of January 14, 2024
NUPLAZID (pimavanserin tartrate) Acadia pharms inc Patent: 10,028,944 Expiration: Jan 15, 2024 See More … For more information on how
Drug Patent Expirations for the Week of January 14, 2024 Read Post »
New patent expiration for Bausch And drug PROLENSA
Annual Drug Patent Expirations for PROLENSA Prolensa is a drug marketed by Bausch And Lomb and is included in one
New patent expiration for Bausch And drug PROLENSA Read Post »
New patent expiration for Btcp Pharma drug LAZANDA
Annual Drug Patent Expirations for LAZANDA Lazanda is a drug marketed by Btcp Pharma and is included in one NDA.
New patent expiration for Btcp Pharma drug LAZANDA Read Post »
New patent expiration for Acadia Pharms drug NUPLAZID
Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two
New patent expiration for Acadia Pharms drug NUPLAZID Read Post »
New patent expiration for Cubist Pharms drug DIFICID
Annual Drug Patent Expirations for DIFICID Dificid is a drug marketed by Cubist Pharms Llc and is included in two
New patent expiration for Cubist Pharms drug DIFICID Read Post »
